Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05524766 · ClinicalTrials.gov registry record · NA
BTL-785F Device for Non-invasive Facial Rejuvenation in Patients Injected With Botulinum Toxin
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05524766 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 13 participants.
The verdict
NCT05524766, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study will evaluate the clinical safety and the efficacy of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive facial treatment in patients injected with botulinum toxin. The aim is to investigate the improvement of overall facial appearance and muscle tone.
Interventions
- DEVICE BTL-785-7 Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-07-06 |
| Est. Completion | 2023-02-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05524766
The ClinicalTrials.gov registry entry for NCT05524766 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BTL-785-7 Treatment is the first listed.
NCT05524766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05524766 about?
NCT05524766 is a clinical study titled "BTL-785F Device for Non-invasive Facial Rejuvenation in Patients Injected With Botulinum Toxin". This study will evaluate the clinical safety and the efficacy of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive facial treatment in patients injected with botulinum toxin. The aim is to investigate the improvement of overall facial appearance and muscle tone.
What is the current status of trial NCT05524766?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-07-06. Estimated completion is 2023-02-08.
What interventions are being tested in trial NCT05524766?
The interventions under investigation include: BTL-785-7 Treatment (DEVICE).
Who is sponsoring clinical trial NCT05524766?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.